AR, androgen receptor, 367

N. diseases: 854; N. variants: 163
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0205969
Disease: Thymic Carcinoma
Thymic Carcinoma
0.010 AlteredExpression disease BEFREE To this end we screened 35 normal and 23 hyperplastic thymuses, 127 thymomas and 41 thymic carcinomas for the presence of sebaceous differentiation as defined by morphology and expression of adipophilin and androgen receptor (AR). 31401665 2020
CUI: C0206686
Disease: Adrenocortical carcinoma
Adrenocortical carcinoma
0.010 AlteredExpression disease BEFREE The survival analysis showed that high AR mRNA is associated with poor survival of stomach adenocarcinoma and low-grade glioma, but better survival of adrenocortical carcinoma, kidney renal clear cell carcinoma, acute myeloid leukemia, liver hepatocellular carcinoma, ovarian serous cystadenocarcinoma, and skin cutaneous melanoma based on AR mRNA, protein or AR-score. 31759122 2020
CUI: C0278701
Disease: Gastric Adenocarcinoma
Gastric Adenocarcinoma
0.010 AlteredExpression disease BEFREE The survival analysis showed that high AR mRNA is associated with poor survival of stomach adenocarcinoma and low-grade glioma, but better survival of adrenocortical carcinoma, kidney renal clear cell carcinoma, acute myeloid leukemia, liver hepatocellular carcinoma, ovarian serous cystadenocarcinoma, and skin cutaneous melanoma based on AR mRNA, protein or AR-score. 31759122 2020
CUI: C1176475
Disease: Ductal Carcinoma
Ductal Carcinoma
0.010 Biomarker disease BEFREE The objective is to study the following: (a) Expression of AR in resection specimens of ductal carcinomas, (b) Relationship of AR with clinicopathologic features, ER, PR, and Her-2 status. 31603099 2020
High Grade Cervical Intraepithelial Neoplasia
0.010 GeneticVariation disease BEFREE Prevalence of human papillomavirus (HPV)-vaccine types by race/ethnicity and sociodemographic factors in women with high-grade cervical intraepithelial neoplasia (CIN2/3/AIS), Alameda County, California, United States. 31611099 2020
CUI: C1997217
Disease: Low grade glioma
Low grade glioma
0.010 AlteredExpression disease BEFREE The survival analysis showed that high AR mRNA is associated with poor survival of stomach adenocarcinoma and low-grade glioma, but better survival of adrenocortical carcinoma, kidney renal clear cell carcinoma, acute myeloid leukemia, liver hepatocellular carcinoma, ovarian serous cystadenocarcinoma, and skin cutaneous melanoma based on AR mRNA, protein or AR-score. 31759122 2020
CUI: C0003537
Disease: Aphasia
Aphasia
0.010 Biomarker disease BEFREE Seizures are the most frequent cause of mimic, but isolated speech impairment, among adult-onset epilepsy, is quite rare, while aphasia is more often due to an AIS. 31213383 2019
CUI: C0004096
Disease: Asthma
Asthma
0.010 AlteredExpression disease BEFREE Our data show AR expression is increased in female ASM with asthma, but has retained functionality that could be used to reduce [Ca<sup>2+</sup>]<sub>i</sub> towards alleviating airway hyperresponsiveness. 31299143 2019
CUI: C0009241
Disease: Cognition Disorders
Cognition Disorders
0.010 Biomarker group BEFREE The AR antagonist darolutamide demonstrated a comparable incidence of cognitive disorder in clinical trials to that of ADT alone. 31844181 2019
CUI: C0009447
Disease: Common Variable Immunodeficiency
Common Variable Immunodeficiency
0.010 GeneticVariation disease BEFREE Using the methylation profile of the human androgen receptor (AR) gene as a surrogate epigenetic marker for bone marrow clonality, we examined the hematopoietic compartments of patients with CVID. 31341110 2019
CUI: C0013146
Disease: Drug abuse
Drug abuse
0.010 Biomarker group BEFREE For future investigations, it is of importance whether the yeast androgen screen, which has been proven to detect androgenic compounds in urine, can detect an abuse of the selective androgen receptor modulators. 30825507 2019
CUI: C0015672
Disease: Fatigue
Fatigue
0.010 Biomarker phenotype BEFREE The approved second-generation androgen receptor (AR) inhibitors enzalutamide and apalutamide were associated with some CNS-related adverse events (AEs) in clinical studies, including fatigue (which can interfere with cognitive function). 31844181 2019
CUI: C0018055
Disease: Gonadal Dysgenesis, Mixed
Gonadal Dysgenesis, Mixed
0.010 AlteredExpression disease BEFREE Measurement of AR mRNA expression levels, AR activity [DHT-mediated APOD (apolipoprotein D) induction] and cellular 45,X/46,XY ratios in genital skin fibroblasts from individuals with 45,X/46,XY mosaicism and male reference individuals, and determination of the external virilization scale from individuals with 45,X/46,XY mosaicism. 31180485 2019
CUI: C0018203
Disease: Chronic granulomatous disease
Chronic granulomatous disease
0.010 GeneticVariation group BEFREE The patient showed an extremely skewed (≥96%) X inactivation pattern of the HUMARA locus; this inactivation is thought to be responsible for the development of CGD not only in neutrophils but also in monocytic, T-cell, and B-cell lineages and in CD34-positive immature hematopoietic cells. 30633606 2019
CUI: C0020500
Disease: Hyperoxaluria
Hyperoxaluria
0.010 Biomarker disease BEFREE Together, results from multiple preclinical studies using multiple in vitro cell lines and in vivo mouse/rat models all demonstrated that targeting the AR with a small molecule ASC-J9® may function via altering macrophage recruitment/M2 polarization to decrease the intrarenal CaOx crystals deposition, a key phenotype seen in many kidney stone disease patients with hyperoxaluria. 30894518 2019
CUI: C0020651
Disease: Hypotension, Orthostatic
Hypotension, Orthostatic
0.010 Biomarker phenotype BEFREE <b>Participants</b>: Inpatients who had a C4-T6 SCI (AIS A-D) less than 12 weeks before recruitment, and reported symptoms of OH in their medical chart. 31573450 2019
CUI: C0020676
Disease: Hypothyroidism
Hypothyroidism
0.010 AlteredExpression disease BEFREE Therefore, the study suggests that hypothyroidism could affect male reproductive function by disturbing expression of AR, changing the activity of Ca<sup>2+</sup>-ATPase, inducing oxidative stress and then leading to activation of p38MAPK and JNK signaling in the testicular mitochondria. 29896988 2019
CUI: C0023652
Disease: Lichen Sclerosus et Atrophicus
Lichen Sclerosus et Atrophicus
0.010 Biomarker disease BEFREE Markers of oxidative stress, cell cycle dysregulation and the androgen receptor do not appear to be uniquely associated with lichen sclerosus urethral stricture disease. 30835614 2019
CUI: C0025319
Disease: Menopausal syndrome
Menopausal syndrome
0.010 Biomarker disease BEFREE The occurrence of male climacteric syndrome was related to the CAG repeat number of androgen receptor gene, and the male patients with more CAG repeats had higher risk of clinical syndrome of climacteric. 30043577 2019
CUI: C0029458
Disease: Osteoporosis, Postmenopausal
Osteoporosis, Postmenopausal
0.010 Biomarker disease BEFREE Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis. 29785666 2019
CUI: C0029925
Disease: Ovarian Carcinoma
Ovarian Carcinoma
0.010 Biomarker disease BEFREE Hierarchical clustering by PR, ER and AR histoscores identified four EnOC subgroups (PR+/ER+, PR+/ER-, PR-/ER+ and PR-/ER-). 31495455 2019
CUI: C0031090
Disease: Periodontal Diseases
Periodontal Diseases
0.010 Biomarker group BEFREE Herein, we investigated the role of androgen receptor and TES on the inflammatory response and alveolar bone resorption associated with ligature-induced periodontal disease in female rats. 31389012 2019
CUI: C0031099
Disease: Periodontitis
Periodontitis
0.010 AlteredExpression disease BEFREE The blockage of androgen receptor significantly increased radiographic bone loss and tissue levels of IL-1α (P <0.05), IL-1β (P <0.001) and IL-10 (P <0.01) compared with the periodontitis group. 31389012 2019
CUI: C0036572
Disease: Seizures
Seizures
0.010 Biomarker phenotype BEFREE The ARAMIS trial on darolutamide, another AR pathway inhibitor, is also ongoing, and can potentially be another fitting option for M0CRPC. 30115959 2019
CUI: C0042870
Disease: Vitamin D Deficiency
Vitamin D Deficiency
0.010 AlteredExpression disease BEFREE Vascular reactivity showed similar alterations: in females, testosterone constricted the ACA only after combined VDD and hyperandrogenism, whereas in males VDD resulted in increased testosterone-induced contractions in spite of decreased androgen receptor expression. 31083690 2019